VRd (HR, 0.652; 95% CI, 0.259–1.640) but did not reach statistical significance.
← all excerpts
Comparative Effectiveness and Safety of PI-Rd Triplets in Relapsed/Refractory Multiple Myeloma: INSIGHT-MM Data Analysis.
1
—
—
VRd (HR, 0.652; 95% CI, 0.259–1.640) but did not reach statistical significance.